Novel therapeutics, enhancements to existing treatments, and new uses for existing compounds are all of interest to LSGPA. In particular, we seek potential investments in translational stage therapeutics (late preclinical to early clinical) from academic labs and young discovery companies. Innovative CROs and novel approaches to clinical trials management will also be considered.
Azevan Pharmaceuticals, Inc.Bethlehem, PAAzevan Pharmaceuticals, Inc., is a clinical stage, small molecule drug development company developing...Read More
Deltagen Bioservices, Inc.Malvern, PADeltagen provides high quality, regulatory-compliant services supporting the development and commercialization of biopharmaceutical...Read More
Immunomic Therapeutics, Inc.Lancaster, PAImmunomic Therapeutics, Inc., (ITI) is a clinical stage biotechnology company with a novel...Read More
Indigo Biosciences, Inc.State College, PAIndigo Biosciences offers to academic labs, contract research organizations, and pharmaceutical and biotechnology...Read More
Ras Therapeutics, Inc.Harrisburg, PARas Therapeutics, named for a protein involved in a critical pathway for cancer...Read More
